A controlled clinical trial of small daily doses of rifampicin in the prevention of adverse reactions to the drug in a once‐weekly regimen of chemotherapy
- 1 March 1974
- journal article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 4 (1) , 1-12
- https://doi.org/10.1111/j.1365-2222.1974.tb01357.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Adverse Reactions to Daily and Intermittent Rifampicin Regimens for Pulmonary Tuberculosis in Hong KongBMJ, 1972
- Accident transfusionnel de type anaphylactique en rapport avec un anticorps anti-IgARevue Française de Transfusion Et Immuno-Hématologie, 1971
- General considerations in intermittent drug therapy of pulmonary tuberculosisPublished by Oxford University Press (OUP) ,1971
- Potentially Serious Side Effects of High-dose Twice-weekly RifampicinBMJ, 1971
- Rifampicin-induced Immune ThrombocytopeniaBMJ, 1970
- Anaphylactic Transfusion Reactions Associated with Anti-IgA AntibodyNew England Journal of Medicine, 1969
- The Mechanism of Immunological ParalysisPublished by Elsevier ,1968
- Induction of immunological paralysis in two zones of dosageProceedings of the Royal Society of London. B. Biological Sciences, 1964
- Ethionamide, pyrazinamide and cycloserine in the treatment of drug-resistant pulmonary tuberculosisTubercle, 1963